Correlation Between Seres Therapeutics and Nuvation Bio
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Nuvation Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Nuvation Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Nuvation Bio, you can compare the effects of market volatilities on Seres Therapeutics and Nuvation Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Nuvation Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Nuvation Bio.
Diversification Opportunities for Seres Therapeutics and Nuvation Bio
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Seres and Nuvation is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Nuvation Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvation Bio and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Nuvation Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvation Bio has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Nuvation Bio go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Nuvation Bio
Given the investment horizon of 90 days Seres Therapeutics is expected to generate 1.92 times more return on investment than Nuvation Bio. However, Seres Therapeutics is 1.92 times more volatile than Nuvation Bio. It trades about 0.16 of its potential returns per unit of risk. Nuvation Bio is currently generating about 0.24 per unit of risk. If you would invest 70.00 in Seres Therapeutics on August 28, 2024 and sell it today you would earn a total of 18.00 from holding Seres Therapeutics or generate 25.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Seres Therapeutics vs. Nuvation Bio
Performance |
| Timeline |
| Seres Therapeutics |
| Nuvation Bio |
Seres Therapeutics and Nuvation Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Seres Therapeutics and Nuvation Bio
The main advantage of trading using opposite Seres Therapeutics and Nuvation Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Nuvation Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvation Bio will offset losses from the drop in Nuvation Bio's long position.| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
| Nuvation Bio vs. Eliem Therapeutics | Nuvation Bio vs. Scpharmaceuticals | Nuvation Bio vs. Milestone Pharmaceuticals | Nuvation Bio vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |